Daily Brief Archive: July 11, 2026 — U.S. & Hong Kong Stock Analysis
Free previewU.S. Markets
- S&P +0.8% a step from records, Nasdaq +1.3% — AI megacaps carried the index while 9 of 11 sectors fell
- META +6%, positive YTD: Meta Compute AI cloud unveiled, in-house Iris chip enters production in September
- SKHY closed its debut +13% at $168 — the $26.5B IPO is the largest-ever US listing by a foreign company
- Delta beat on both lines yet fell 2.8% — fuel costs ate the margin imagination
- IONS slid another 9.4% (-31% in two days) as biotech split: XBI -3.2% while BBIO held its highs
Hong Kong
- HSI +0.6%, tech index -0.21%: a double unlock hit — Zhipu and MiniMax first-tranche expiries torched tech
- Semis routed: GigaDevice -21% (unlock 7/13), Iluvatar -19%, Victory Giant -13%
- CK Hutchison +7.5% led blue chips on Hutchison Ports' green-port MOUs with Midea and TCL
- Commercial aerospace spiked and biotech firmed — where the money fleeing chips landed
- CATL's H-shares fell 7.9% as the battery chain resonated lower with lithium prices
Today's Watchlist
- Monday 7/13: GigaDevice's H-share unlock lands — stress-test day for HK's chip chain
- Today's actions: all 48 positions held; stops raised on META, NVDA and AMD to lock gains
- Tencent closed at HK$460.20, one step above the HK$450 stop — Monday is the decision day
- Earnings accelerate next week: big banks from 7/14, then SYF 7/21 and TSLA 7/22
- SKHY holding above its $149 offer price is the memory bulls' baseline signal
Deep Dives (0 names)
No deep-dive names match the current filters
Rapid Scan (9 names)
| Ticker | Close | Change | Score | Direction | One-line take |
|---|---|---|---|---|---|
| $152.65 | +2.58% | 7 | Neutral | Up 2.6% to a 52-week high — 13 analysts, all Buys, +19% on the month; at RSI 67.7, participation talk waits for the retest | |
| $82.76 | +5.53% | 6 | Neutral | Up 5.5% to a 52-week high with a +20% month; RSI 72 is hot — right company, right trend, wrong entry | |
| $132.78 | +4.44% | 6 | Neutral | Up 4.4% at 52-week highs in a +54% YTD clog renaissance; price already 5% past analyst targets | |
| $104.15 | +1.30% | 6 | Neutral | Up 1.3% into 52-week-high ground, the turnaround +31% YTD; a valid breakout with just 3% left to consensus targets | |
| $31.02 | +1.44% | 5 | Neutral | Up 1.4%, front-running regional-bank earnings week at the 94th percentile with RSI 65; the event window nears | |
| $242.34 | +1.85% | 5 | Neutral | Up 1.8% at 52-week highs awaiting results; the regional-bank breakout needs next week's numbers to co-sign | |
| $251.91 | +0.40% | 5 | Neutral | Up 0.4%, consolidating at the 95th percentile — the large regional's pre-earnings outpost | |
| $123.9 | +0.06% | 6 | Neutral | Up 0.1%, closing at the 100th percentile — the precision-oncology upstart tightropes along all-time highs at RSI 67.5 | |
| $97.56 | +1.07% | 5 | Neutral | Up 1.1% at a scorching RSI 77; the breakout extends but the stretch has warped the chasing odds |